Literature DB >> 23926228

Exploring the role of human miRNAs in virus-host interactions using systematic overlap analysis.

Zhenpeng Li1, Xiuliang Cui, Fei Li, Peng Li, Ming Ni, Shengqi Wang, Xiaochen Bo.   

Abstract

MOTIVATION: Human miRNAs have recently been found to have important roles in viral replication. Understanding the patterns and details of human miRNA interactions during virus-host interactions may help uncover novel antiviral therapies. Based on the abundance of knowledge available regarding protein-protein interactions (PPI), virus-host protein interactions, experimentally validated human miRNA-target pairs and transcriptional regulation of human miRNAs, it is possible to explore the complex regulatory network that exists between viral proteins and human miRNAs at the system level.
RESULTS: By integrating current data regarding the virus-human interactome and human miRNA-target pairs, the overlap between targets of viral proteins and human miRNAs was identified and found to represent topologically important proteins (e.g. hubs or bottlenecks) at the global center of the human PPI network. Viral proteins and human miRNAs were also found to significantly target human PPI pairs. Furthermore, an overlap analysis of virus targets and transcription factors (TFs) of human miRNAs revealed that viral proteins preferentially target human miRNA TFs, representing a new pattern of virus-host interactions. Potential feedback loops formed by viruses, human miRNAs and miRNA TFs were also identified, and these may be exploited by viruses resulting in greater virulence and more effective replication strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23926228     DOI: 10.1093/bioinformatics/btt391

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  7 in total

Review 1.  MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections.

Authors:  Sonia R Isaacs; Jie Wang; Ki Wook Kim; Congcong Yin; Li Zhou; Qing Sheng Mi; Maria E Craig
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

2.  Human MicroRNA miR-532-5p Exhibits Antiviral Activity against West Nile Virus via Suppression of Host Genes SESTD1 and TAB3 Required for Virus Replication.

Authors:  Andrii Slonchak; Rory P Shannon; Gabor Pali; Alexander A Khromykh
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

3.  Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program.

Authors:  Feng Xu; Yanhua Kang; Ningtong Zhuang; Zhe Lu; Hang Zhang; Dakang Xu; Yina Ding; Hongping Yin; Liyun Shi
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

4.  Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors.

Authors:  Andrea Latini; Chiara Vancheri; Francesca Amati; Elena Morini; Sandro Grelli; Matteucci Claudia; Petrone Vita; Vito Luigi Colona; Michela Murdocca; Massimo Andreoni; Vincenzo Malagnino; Massimiliano Raponi; Dario Cocciadiferro; Antonio Novelli; Paola Borgiani; Giuseppe Novelli
Journal:  J Cell Mol Med       Date:  2022-09-08       Impact factor: 5.295

Review 5.  Implications of MicroRNAs in Oncolytic Virotherapy.

Authors:  Xavier Bofill-De Ros; Maria Rovira-Rigau; Cristina Fillat
Journal:  Front Oncol       Date:  2017-07-04       Impact factor: 6.244

6.  MicroRNA-221-5p Inhibits Porcine Epidemic Diarrhea Virus Replication by Targeting Genomic Viral RNA and Activating the NF-κB Pathway.

Authors:  Hongqing Zheng; Lei Xu; Yuzhong Liu; Cheng Li; Liang Zhang; Tao Wang; Di Zhao; Xingang Xu; Yanming Zhang
Journal:  Int J Mol Sci       Date:  2018-10-29       Impact factor: 5.923

7.  Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis.

Authors:  Rahila Sardar; Deepshikha Satish; Dinesh Gupta
Journal:  Front Genet       Date:  2020-10-14       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.